Cambrex logo

CBM - Cambrex News Story

$59.99 0.0  0.0%

Last Trade - 03/12/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £483.2m
Position in Universe th / 6387

BRIEF-Cambrex To Acquire Avista Pharma Solutions

Tue 20th November, 2018 11:45am
Nov 20 (Reuters) - Cambrex Corp  CBM.N :
    * CAMBREX TO ACQUIRE AVISTA PHARMA SOLUTIONS, ADDING EARLY
STAGE
API AND FINISHED DOSAGE FORM DEVELOPMENT & TESTING SERVICES TO
ITS GLOBAL CONTRACT DEVELOPMENT & MANUFACTURING NETWORK
    * CAMBREX CORP - DEAL FOR APPROXIMATELY $252 MILLION
    * CAMBREX CORP - DEAL FOR APPROXIMATELY $252 MILLION.
    * CAMBREX CORP - CAMBREX EXPECTS TRANSACTION TO BE ACCRETIVE
TO
ADJUSTED EARNINGS PER SHARE IN 2019.
    * CAMBREX CORP - POST DEAL, NET LEVERAGE RATIO, PRO FORMA
FOR
DEAL, EXPECTED TO BE ABOUT 2.4 TIMES EBITDA
    * CAMBREX CORP - AVISTA'S 330 PERSON WORKFORCE WILL JOIN
CAMBREX'S
1,700 EMPLOYEES ACROSS UNITED STATES AND EUROPE
    * CAMBREX CORP - HAS SECURED COMMITTED FINANCING FOR
PROPOSED
INCREASE
    * CAMBREX - DEAL IS EXPECTED TO BE FUNDED WITH COMBINATION
OF CASH
& BORROWINGS UNDER CO'S EXISTING REVOLVING CREDIT FACILITY
    * CAMBREX CORP -  CAMBREX'S EXISTING REVOLVING CREDIT
FACILITY
WILL BE INCREASED THROUGH ACCORDION FEATURE

Source text for Eikon:  ID:nGNX1Ccjtj 
Further company coverage:  CBM.N 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.